Location History:
- Fort Worth, TX (US) (2016 - 2017)
- Vestal, NY (US) (2019)
Company Filing History:
2 out of 188 
2 out of 5,469 
1 out of 1,274 
Years Active: 2016-2019
Title: The Innovative Contributions of Anthony J Di Pasqua
Introduction
Anthony J Di Pasqua is a notable inventor based in Fort Worth, TX (US). He has made significant contributions to the field of cancer treatment through his innovative work on iron garnet nanoparticles. With a total of 3 patents, his inventions focus on enhancing the efficacy of radiotherapy and chemotherapy.
Latest Patents
One of his latest patents involves the development of iron garnet nanoparticles for cancer radiotherapy and chemotherapy. This invention discloses iron garnet nanoparticles and particles containing various activatable nuclides, such as holmium-165 (Ho) and dysprosium-164 (Dy). The nanoparticles can be prepared using hydroxide co-precipitation methods. In certain embodiments, radiosensitizers can be loaded onto radioactive magnetic nanoparticles or radioactive iron garnet particles, which may also be coated with suitable lipid bilayers. The methods outlined in this patent aim to mediate therapeutic benefits in diseases that respond to radiation therapy. Additionally, the invention provides films, electrospun fabrics, or bandage coverings for delivering radiation to skin lesions that are amenable to treatment, such as skin cancers or psoriasis.
Career Highlights
Throughout his career, Anthony has worked with esteemed institutions, including the University of North Texas and the University of Texas System. His research has focused on innovative solutions to complex medical challenges, particularly in the realm of cancer treatment.
Collaborations
Anthony has collaborated with notable colleagues, including Kenneth J Balkus, Jr and Imalka S Munaweera. These partnerships have contributed to the advancement of his research and the development of his patents.
Conclusion
Anthony J Di Pasqua's work exemplifies the intersection of innovation and healthcare. His contributions to the field of cancer treatment through the development of iron garnet nanoparticles highlight the potential of scientific research to improve patient outcomes.